Association of apolipoprotein allele ε2 with psoriasis vulgaris in Japanese population

Archives of Dermatological Research

Volumn 289, Issue 9, 1997, Pages 497-500

  Furumoto, Hiroko ^a   Nakamura, Kazuyuki ^a   Imamura, Takashi ^b   Hamamoto, Yoshiaki ^a   Shimizu, Takahiro ^a   Muto, Masahiko ^a   Asagami, Chidori ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KOKURA MEMORIAL HOSPITAL   (Japan)

Author keywords

Apolipoprotein E; Japanese; Psoriasis vulgaris

Indexed keywords

APOLIPOPROTEIN E;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HUMAN; IMMUNOBLOTTING; ISOELECTRIC FOCUSING; JAPAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS VULGARIS;

ADOLESCENT; ADULT; AGED; ALLELES; APOLIPOPROTEINS E; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; HUMANS; JAPAN; MALE; MIDDLE AGED; PHENOTYPE; PSORIASIS;

EID: 0030818345     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050229     Document Type: Article

References (25)

1. 4, but not 12-hydroxyeicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions. J Invest Dermatol 92: 837-841
2. Breslow JL (1988) Apo E. Physiol Rev 68: 85-126
3. Miyauchi H (1991) Immunohistochemical study tor the localization of apolipoprotein AI, B100, and E in normal and psoriatic skin. Igaku Kenkyu 61: 79-86
4. Kelly ME, Clay MA, Mistry MJ, Hsieh-Li H-M, Harmony JAK (1994) Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of Interleukin 2 with reduced biological activity. Cell Immunol 159: 124-139
5. B boundary. Cell Immunol 160: 14-23
6. Weisgraber KH (1994) Apolipoprotein E structure-function relationships. Adv Protein Chem 45: 249-302
7. Vahlquist C, Michaëlsson G, Vessby B (1987) Serum lipoproteins in middle-aged men with psoriasis. Acta Derm Venereol (Stockh) 67: 12-15
8. McDonald CJ, Calabresi P (1978) Psoriasis and occlusive vascular disease. Br J Dermatol 99:469-475
9. Kataoka S, Paidi M, Howard BV (1994) Simplified isoelectric focusing /immunoblotting determination of apolipoprotein E phenotype. Clin Chem 40: 11-13
10. Telfer NR, Chalmers RJG, Whale K, Colman G (1992) The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol 128:39-42
11. Hsia SH, Connelly PW, Hegele RA (1995) Restriction isotyping of apolipoprotein E R145C in type III hyperlipoproteinemia. J Invest Med 43: 187-194
12. Seckin D, Tokgozoglu L, Akkaya S (1994) Are lipoprotein profile and lipoprotein (a) levels altered in men with psoriasis? J Am Acad Dermatol 31: 445-449
13. Seishima M, Seishima M, Mori S, Noma A (1994) Serum lipid and apolipoprotein levels in patients with psoriasis. Br J Dermatol 130: 738-742
14. Fenjves ES, Gordon DA, Pershing LK, Williams DL, Taichman LB (1989) Systemic distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes: implications for epidermal function and gene therapy. Proc Natl Acad Sci USA 86: 8803-8807
15. Barra RM, Fenjves ES, Taichman LB (1994) Secretion of apolipoprotein E by basal cells in cultures of epidermal keratinocytes. J Invest Dermatol 102: 61-66
16. Gordon DA, Fenjves ES, Williams DL, Taichman LB (1989) Synthesis and secretion of apolipoprotein E by cultured human keratinocytes. J Invest Dermatol 92: 96-99
17. Elias PM (1981) Lipids and the epidermal permeability barrier. Arch Dermatol Res 270: 95-117
18. Wertz PW, Swartzendruber DC, Abraham W, Madison KC, Downing DT (1987) Essential fatty acids and epidermal integrity. Arch Dermatol 123: 1381-1384
19. Williams ML, Mommaas-Kienhuis A-M, Rutherford SL, Grayson S, Vermeer BJ, Elias PM (1987) Free sterol metabolism and low density lipoprotein receptor expression as differentiation markers of cultured human keratinocytes. J Cell Physiol 132: 428-440
20. Mommaus M, Tada J, Ponec M (1991) Distribution of low-density lipoprotein receptors and apolipoprotein B on normal and on reconstructed human epidermis. J Dermatol Sci 2: 97-105
21. Schopf E, Mueller JM, Ostermann T (1995) Value of adjuvant basic therapy in chronic recurrent skin diseases. Neurodermatitis atopica/psoriasis vulgaris. Hautarzt 46: 451-454
22. Jones CH, Longley MA, Bundman D, Bickenbach JR, Roop DR (1996) Targeted expression of apolipoprotein E in the epidermis of transgenic mice results in lipid accumulation and neonatal lethality (abstract). J Invest Dermatol 106: 810
23. Pushkareva M, Obeid LM, Hannun YA (1995) Ceramide: an endogenous regulator of apoptosis and growth suppression. Immunol Today 16: 294-297
24. Duan H, Li Z, Mazzone T (1995) Tumor necrosis factor-α modulates monocyte/macrophage apoprotein E gene expression. J Clin Invest 96: 915-922
25. Hamamoto Y, Nagai K, Muto M, Furumoto H, Mogami S, Asagami C (1996) Establishment and characterization of a novel human promonocytic cell line from peripheral blood of a patient with psoriasis. Arch Dermatol Res 288: 225-229